临床I期肺腺癌的CT影像基因组学分析:组织病理学特征与肿瘤学结局
该回顾性研究纳入219例接受完整手术切除的临床I期肺腺癌患者,基于术前CT提取影像组学特征并以共识聚类分为4组,分析各组与组织病理亚型、基因改变及复发特异性生存的关联。结果显示聚类1与贴壁型、腺泡型、乳头型亚型及EGFR改变相关,聚类4与实性/微乳头亚型、STK11及PI3K通路改变、淋巴血管侵犯、气腔播散及最高复发风险相关。
要点
- 基于术前CT的影像组学共识聚类可分为4组,与肺腺癌病理亚型和基因改变相关。
- 聚类1以贴壁型、腺泡型、乳头型为主(84%),EGFR改变比例最高(42%)。
- 聚类4与实性/微乳头亚型、STK11及PI3K通路改变、复发风险最高相关。
核心结论
- 基于CT的影像组学共识聚类可识别临床I期肺腺癌影像组学特征与临床病理、基因组特征及结局之间的关联。
研究设计与样本
- 回顾性研究,纳入2014年4月至2017年12月接受完整手术切除、有术前CT及下一代测序数据的肺腺癌患者219例(中位年龄68岁,四分位距63-74岁,女性150例[68%]);对术前CT行影像组学分析,肿瘤分为实性、磨玻璃或混合型,采用共识聚类分组,并与基因组改变、组织病理特征及复发特异性生存比较。
关键影像表现/征象
- 聚类1与贴壁型、腺泡型及乳头型亚型相关(90例中76例[84%])。
- 聚类2(50例中13例[26%])和聚类4(45例中13例[29%])与实性及微乳头亚型相关(P < .001)。
- 聚类2、3、4分别与淋巴血管侵犯相关(50例中19例[38%]、34例中14例[41%]、45例中28例[62%],P < .001)。
- 聚类2、3、4分别与气腔播散相关(50例中32例[64%]、34例中21例[62%]、45例中31例[69%],P < .001)。
诊断标准与关键数值
- 聚类1中EGFR改变比例最高(90例中38例[42%],P = .004)。
- 聚类4中STK11改变比例最高(45例中14例[31%],P = .006)。
- 聚类4中磷酸肌醇3-激酶通路改变比例最高(45例中22例[49%],P < .001)。
- 聚类4复发风险最高(log-rank P < .001)。
临床应用与阅片要点
- 术前CT影像组学聚类可能有助于识别临床I期肺腺癌中病理亚型及基因改变相关的影像特征。
- 聚类4特征与实性/微乳头亚型、STK11及PI3K通路改变、淋巴血管侵犯、气腔播散及最高复发风险相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background A preoperative predictive model is needed that can be used to identify patients with lung adenocarcinoma (LUAD) who have a higher risk of recurrence or metastasis. Purpose To investigate associations between CT-based radiomic consensus clustering of stage I LUAD and clinical-pathologic features, genomic data, and patient outcomes. Materials and Methods Patients who underwent complete surgical resection for LUAD from April 2014 to December 2017 with preoperative CT and next-generation sequencing data were retrospectively identified. Comprehensive radiomic analysis was performed on preoperative CT images; tumors were classified as solid, ground glass, or mixed. Patients were clustered into groups based on their radiomics features using consensus clustering, and clusters were compared with tumor genomic alterations, histopathologic features, and recurrence-specific survival (Kruskal-Wallis test for continuous data, χ2 or Fisher exact test for categorical data, and log-rank test for recurrence-specific survival). Cluster analysis was performed on the entire cohort and on the solid, ground-glass, and mixed lesion subgroups. Results In total, 219 patients were included in the study (median age, 68 years; interquartile range, 63-74 years; 150 [68%] women). Four radiomic clusters were identified. Cluster 1 was associated with lepidic, acinar, and papillary subtypes (76 of 90 [84%]); clusters 2 (13 of 50 [26%]) and 4 (13 of 45 [29%]) were associated with solid and micropapillary subtypes (P < .001). The EGFR alterations were highest in cluster 1 (38 of 90 [42%], P = .004). Clusters 2, 3, and 4 were associated with lymphovascular invasion (19 of 50 [38%], 14 of 34 [41%], and 28 of 45 [62%], respectively; P < .001) and tumor spread through air spaces (32 of 50 [64%], 21 of 34 [62%], and 31 of 45 [69%], respectively; P < .001). STK11 alterations (14 of 45 [31%]; P = .006), phosphoinositide 3-kinase pathway alterations (22 of 45 [49%], P < .001), and risk of recurrence (log-rank P < .001) were highest in cluster 4. Conclusion CT-based radiomic consensus clustering enabled identification of associations between radiomic features and clinicalpathologic and genomic features and outcomes in patients with clinical stage I lung adenocarcinoma. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Nishino in this issue.
引用
- Perez-Johnston, Araujo-Filho, Connolly, et al. CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic Outcomes. Radiology. 2022. PMID: 35230187. doi:10.1148/radiol.211582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。